Docoh
Loading...

FWP Forward Pharma A/S

Filed: 4 May 21, 6:00am

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

May 3, 2021

 

Commission File Number: 001-36686

 

Forward Pharma A/S

 

Østergade 24A, 1st Floor

1100 Copenhagen K, Denmark

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ☒Form 40-F  ☐  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

 

 

 

Item 1. Notice to Convene Annual General Meeting

 

On May 3, 2021, Forward Pharma A/S (the “Company”) mailed to its shareholders a notice to convene the 2021 annual general meeting of shareholders on May 27, 2021 and accompanying documentation. The notice and accompanying documentation have been posted on the Company’s website, http://forward-pharma.com, and are being furnished as exhibits to this Report on Form 6-K.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 FORWARD PHARMA A/S 
    
    
Date: May 3, 2021By:/s/ Claus Bo Svendsen 
  Name: Claus Bo Svendsen 
  Title: Chief Executive Officer 

 

 

 

 

 

 

 

 

 

 

 

EXHIBIT INDEX

 

99.1Notice to Convene Annual General Meeting
99.2Proxy/Voting by Correspondence Form
99.3Request for Admission Card
99.4Share Capital and Voting Rights